GTC
Ghost Tree Capital Portfolio holdings
AUM
$276M
This Quarter Return
-15.87%
1 Year Return
+49.13%
3 Year Return
+198.45%
5 Year Return
+1,783.74%
10 Year Return
+9,775.89%
AUM
$203M
AUM Growth
+$203M
(-48%)
Cap. Flow
-$126M
Cap. Flow
% of AUM
-61.88%
Top 10 Holdings %
Top 10 Hldgs %
54.94%
Holding
59
New
7
Increased
8
Reduced
10
Closed
22
Top Buys
| 1 |
Vertex Pharmaceuticals
VRTX
|
$13.3M |
| 2 |
Iovance Biotherapeutics
IOVA
|
$8.85M |
| 3 |
BOLD
Audentes Therapeutics, Inc
BOLD
|
$6.4M |
| 4 |
Amicus Therapeutics
FOLD
|
$6.23M |
| 5 |
AnaptysBio
ANAB
|
$5.1M |
Top Sells
| 1 |
PTC Therapeutics
PTCT
|
$23.5M |
| 2 |
ECYT
Endocyte, Inc. Common Stock
ECYT
|
$19.5M |
| 3 |
TSRO
TESARO, Inc.
TSRO
|
$17.6M |
| 4 |
Sarepta Therapeutics
SRPT
|
$15.3M |
| 5 |
Assembly Biosciences
ASMB
|
$12.1M |
Sector Composition
| 1 | Healthcare | 82.98% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
BLUE
51
DELISTED
bluebird bio
BLUE
| – | – |
-75,000
| Closed | -$11M |
|
|
AVDL
52
Avadel Pharmaceuticals
AVDL
$1.42B
| – | – |
-450,000
| Closed | -$1.98M |
|
|
53
Assembly Biosciences
ASMB
$183M
| – | – |
-325,000
| Closed | -$12.1M |
|
54
argenx
ARGX
$44.2B
| – | – |
-125,000
| Closed | -$9.48M |
|
55
Apellis Pharmaceuticals
APLS
$3.51B
| – | – |
-185,000
| Closed | -$3.29M |
|
|
ALLK
56
DELISTED
Allakos
ALLK
| – | – |
-75,000
| Closed | -$3.37M |
|
|
PTLA
57
DELISTED
Portola Pharmaceuticals, Inc.
PTLA
| – | – |
-300,000
| Closed | -$7.99M |
|
|
NEOS
58
DELISTED
Neos Therapeutics, Inc
NEOS
| – | – |
-482,600
| Closed | -$2.34M |
|
|
ZGNX
59
DELISTED
Zogenix, Inc.
ZGNX
| – | – |
-200,000
| Closed | -$9.92M |
|